For those with a BMI of 2530 kg/m 2 , the drugs are better positioned as preconception metabolic optimization tools, with an emphasis on post-discontinuation maintenance and washout strategies
This suggests that GLP-1 RAs may be most appropriate for adolescents with established obesity who have not responded to comprehensive lifestyle interventions
It's commonly dosed as a small nightly subcutaneous injection before bed often on a 5-days-on, 2-days-off schedule because GH is naturally released during sleep
PurpleLab, using its healthcare claims database and HealthNexus analytics platform, analyzed medical and pharmacy claims for 12.2M people taking GLP-1 medications from January 2019 May 2024
Helplines outside the U.S
PMID: 40396503, PMCID: PMC12095927, DOI: 10.1177/17407745241304355